RE-Stem Biotech

RE-Stem Biotech is a China-based regenerative medicine and cell therapy company focused on developing and commercializing therapies for osteoarthritis, spinal cord injury, cancer, and other age-related or degenerative conditions. The company states that it operates a technology platform spanning stem cells, immune cells, stem cell-derived products, exosomes, and cell banking, supported by GMP manufacturing capabilities. Its disclosed pipeline includes RE-Kneew for knee osteoarthritis, RE-Enable paired with the Re-Hab procedure for spinal cord injury, and RE-AGN 2.0 for lung and liver cancers. Company materials also indicate that it has multiple therapies and products either on the market or in additional development, with activities centered in China.